Safeplus International Holdings Ltd. (ACAI)
OTC PINK OTC PINK Primary Summary
ACAI Chart
Safeplus International Holdings Ltd. (ACAI) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Safeplus International Holdings Ltd. ever had a stock split?
Safeplus International Holdings Ltd. Profile
| Trading Companies & Distributors Industry | Industrials Sector | Shaocheng Tang CEO | OTC PINK Exchange | 78646R106 CUSIP |
| US Country | 2 Employees | - Last Dividend | 10 Sep 2020 Last Split | 26 Nov 1999 IPO Date |
Overview
Biophan Technologies, Inc., is a pioneering firm rooted in the development and commercialization of advanced technologies for the medical device sector. Since its inception in 1963, the company has established itself as a visionary entity within the industry, focusing on the partnership and monetization of its patented innovations. Based in Pittsford, New York, Biophan is committed to enhancing medical device functionalities, thus contributing to the advancement of healthcare technologies. The company’s drive for excellence is paralleled by its quest to seek partners that share a mutual ambition of revolutionizing medical devices through state-of-the-art technology.
Products and Services
Biophan Technologies is at the forefront of introducing groundbreaking technologies that promise to redefine the medical device industry. Below are some of the company’s notable innovations:
- Biothermal Power Supply: An innovative technology designed to harness the body's natural heat as a power source for medical implants. This novel approach not only offers a sustainable alternative to traditional battery-powered devices but also aims to extend the lifespan of implants, reducing the need for frequent surgical replacements.
- Pulsewidth Modulation Technology: Focused on enhancing the performance of pacemakers and neurostimulators, this technology employs advanced pulsewidth modulation to improve the precision and responsiveness of these critical devices. Such improvements can lead to better patient outcomes by ensuring devices operate more efficiently and in sync with the patient's physiological requirements.
- Photonics and Nanomaterials Patents: Biophan is also pioneering in the fields of photonics and nanomaterials, boasting patents that promise to revolutionize the medical device landscape. These patents encompass innovations that aim to improve device communication, reduce interference, and increase compatibility with diagnostic tools such as MRI machines, ensuring patients have access to safer and more effective treatment options.
